Le capital incinctif a considérablement augmenté sa participation dans Edwards Lifesciences, tandis que CalPERS a vendu des actions de façon significative. Cinctive Capital greatly increased its stake in Edwards Lifesciences, while CalPERS significantly sold off shares.

Gestion de capital incintive LP a augmenté de façon significative sa participation dans Edwards Lifesciences de 166,1%, acquérant 148 923 actions d'une valeur de 11 025 000 $. Cinctive Capital Management LP significantly increased its stake in Edwards Lifesciences by 166.1%, acquiring 148,923 shares worth $11,025,000. Edwards Lifesciences a déclaré un bénéfice par action de 0,59 $, dépassant les estimations de 0,55 $. Edwards Lifesciences reported earnings per share of $0.59, exceeding estimates of $0.55. Toutefois, CalPERS a vendu 288681actions, ce qui a ramené ses participations à787027actions d'une valeur de58264000$. However, CalPERS sold 288,681 shares, reducing its holdings to 787,027 shares worth $58,264,000. Au cours du dernier trimestre, les initiés ont vendu 4 513 064 $ en stock. Over the last quarter, insiders sold $4,513,064 worth of stock.